Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área temáticas
Problemas sociales y servicios a grupos(2)
Enfermedades(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Origen
scopus(2)
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity An Observational Study
ArticleAbstract: Background: The transition to dolutegravir-containing antiretroviral therapy (ART) in low- and middlPalabras claves:Autores:Avihingsanon A., Azwa I., Bernard C., Bijker R., Brazier E., Bui H.V., Cahn P., Cardoso S.W., Castelnuovo B., Cesar C., Chaiwarith R., Chan Y.J., Chitalikar A., Choi J.Y., Chumla L., Cortés C.P., Dell'Isola E., Ditangco R., Do C.D., Edwards J.K., Ezhilarasi C., Fink V., Gaikwad S., Gani Y.M., Gatechompol S., Grinsztejn B., Han N., Humphrey J.M., Imran D., Jiamsakul A., Joshi K., Kamarulzaman A., Kambua P., Kantipong P., Ke E., Kelvin E.A., Khol V., Khuwuwan S., Kiertiburanakul S., Kim J.M., Ku W.W., Kumarasamy N., Kunzekwenyika C., Lam W., Law M.G., Lee L.S., Lee M.P., Li P.C.K., Lim P.L., Ly P.S., Maina M.W., Mationg M.L., Matthew L. Romo, Merati T.P., Musick B.S., Na S., Nash D., Ng O.T., Ngo A.V., Nguyen D.T., Nguyen D.T.H., Nguyen K.V., Nguyen L.T., Nishijima T., Nuket K., Oka S., Panczak R., Pasayan M.K., Patel R.C., Penner J., Perez H., Petersen B., Phadungphon C., Phanuphak P., Phuphuakrat A., Ponnampalavanar S., Praparattanapan J., Pujari S., Ross J.L., Rudi N.B., Rupasinghe D., Sanmeema N., Sirisanthana T., Sohn A.H., Sued O., Syed Omar S.F., Tanuma J., Valiente J., Widhani A., Wirawan D.N., Wong H.Y., Wools-Kaloustian K.K., Wu P.C., Wyka K., Yamamoto C., Yap J.K., Yuliana F., Yunihastuti E., Zhang F.J., Zhao H.X.Fuentes:scopusViral Load Status Before Switching to Dolutegravir-Containing Antiretroviral Therapy and Associations With Human Immunodeficiency Virus Treatment Outcomes in Sub-Saharan Africa
ArticleAbstract: Background: Dolutegravir is being rolled out globally as part of preferred antiretroviral therapy (APalabras claves:antiretroviral agents, clinical decision-making, HIV integrase inhibitors, prognosis, Viral loadAutores:Diero L., Edwards J.K., Kasozi C., Kelvin E.A., Lelo P., Matthew L. Romo, Murenzi G., Musick B.S., Nash D., Odhiambo F., Semeere A.S., Sohn A.H., Urassa M., Wools-Kaloustian K.K., Wyka K.Fuentes:scopus